Proposed Data Collections Submitted for Public Comment and Recommendations, 66532-66533 [E6-19262]
Download as PDF
66532
Federal Register / Vol. 71, No. 220 / Wednesday, November 15, 2006 / Notices
Dated: November 8, 2006.
Joan F. Karr,
Acting Reports Clearance Officer, Centers for
Disease Control and Prevention.
[FR Doc. E6–19260 Filed 11–14–06; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day-07–0469]
Agency Forms Undergoing Paperwork
Reduction Act Review
The Centers for Disease Control and
Prevention (CDC) publishes a list of
information collection requests under
review by the Office of Management and
Budget (OMB) in compliance with the
Paperwork Reduction Act (44 U.S.C.
Chapter 35). To request a copy of these
requests, call the CDC Reports Clearance
Officer at (404) 639–5960 or send an email to omb@cdc.gov. Send written
comments to CDC Desk Officer, Office of
Management and Budget, Washington,
DC or by fax to (202) 395–6974. Written
comments should be received within 30
days of this notice.
Proposed Project
National Program of Cancer
Registries—Cancer Surveillance
System—Extension (OMB number
0920–0469)-National Center for Chronic
Disease Prevention and Health
Promotion (NCCDPHP), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
The American Cancer Society
estimated that about 1.37 million
Americans were newly diagnosed with
cancer in 2005 and that about 570,000
died from cancer in that same year. The
National Institutes of Health estimates
that in 2005, the cost of cancer was
about $209 billion, including $74 billion
direct costs to treat cancer, and $136
billion indirect costs in lost productivity
due to illness and premature death.
In 2002, CDC implemented the
National Program of Cancer Registries
(NPCR)—Cancer Surveillance System
(CSS) to collect, evaluate and
disseminate cancer incidence data
collected by population-based cancer
registries. In 2002, CDC began annually
publishing United States Cancer
Statistics (USCS). The latest USCS
report published in 2005 provided
cancer statistics for 93% of the United
States population from all cancer
registries whose data met national data
standards. Prior to the publication of
USCS, at the national level, cancer
incidence data were available for only
14% of the population of the United
States.
With this expanded coverage of the
U.S. population, it will now be possible
to better describe geographic variation
in cancer incidence throughout the
country and provide incidence data on
minority populations and rare cancers
to further plan and evaluate state and
national cancer control and prevention
efforts.
Therefore, CDC’s Division of Cancer
Prevention and Control proposes to
continue to aggregate existing cancer
incidence data from states funded by the
National Program of Cancer Registries
into a national surveillance system.
These data are already collected and
aggregated at the state level, thus, the
additional burden for the states is small.
Funded states are asked to continue to
report cancer incidence data to CDC on
an annual basis. Each state is requested
to report a cumulative file containing
incidence data from the first diagnosis
year for which the cancer registry
collected data with the assistance of
NPCR funds (e.g., 1995) through 12
months past the close of the most recent
diagnosis year (e.g., 2004).
NCCDPHP is requesting a 3 year
clearance for this project. The total
number of eligible respondents is 63
which includes 50 States, 12 territories,
and the District of Columbia. The total
estimated annualized burden hours are
126 (i.e., 2 hours per respondent). There
are no costs to the respondents other
than their time.
ESTIMATED ANNUALIZED BURDEN HOURS
Respondents
Number of
respondents
Number of
responses
per respondent
Average
burden
per response
(in hours)
States, Territories, and the District of Columbia (Cancer Registries) .........................................
63
1
2
Dated: November 8, 2006.
Joan F. Karr,
Acting Reports Clearance Officer, Centers for
Disease Control and Prevention.
[FR Doc. E6–19261 Filed 11–14–06; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
rmajette on PROD1PC67 with NOTICES1
[60Day–07–06BV]
Proposed Data Collections Submitted
for Public Comment and
Recommendations
In compliance with the requirement
of Section 3506(c)(2)(A) of the
VerDate Aug<31>2005
17:21 Nov 14, 2006
Jkt 211001
Paperwork Reduction Act of 1995 for
opportunity for public comment on
proposed data collection projects, the
Centers for Disease Control and
Prevention (CDC) will publish periodic
summaries of proposed projects. To
request more information on the
proposed projects or to obtain a copy of
the data collection plans and
instruments, call 404–639–5960 and
send comments to Seleda Perryman,
CDC Assistant Reports Clearance
Officer, 1600 Clifton Road, MS–D74,
Atlanta, GA 30333 or send an e-mail to
omb@cdc.gov.
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
PO 00000
Frm 00037
Fmt 4703
Sfmt 4703
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology. Written comments should
be received within 60 days of this
notice.
Proposed Project
Travel-Related Infectious Diseases
Risk Perception, Prevention Measures,
and Behaviors during Travel to Latin
America Visiting Friends and Relatives
(VFR) versus non-VFR Travelers—
New—National Center for Infectious
E:\FR\FM\15NON1.SGM
15NON1
Federal Register / Vol. 71, No. 220 / Wednesday, November 15, 2006 / Notices
Diseases (NCID)—Centers for Disease
Control and Prevention (CDC).
Background and Brief Description
The proposed project will focus on
travelers visiting friends and relatives
(VFR) in Latin America. An estimated
44% of all international travel is VFR
related. Although multiple definitions
exist, VFR travelers typically refer to
those who were born in a resource-poor
country, now living in a resource-rich
country, and returning to their country
of birth to visit friends and relatives.
VFR travelers have received particular
attention recently for being at higher
risk than other travel groups for
acquiring communicable diseases
during visit to their home countries.
However, there are few studies that
66533
theory-driven infectious diseases
prevention messages, both pre-travel
and during travel, that will be specific
to subpopulations of travelers (VFR
versus non-VFR). Expected outcomes of
targeted messaging include reducing
• The burden of illness among
travelers,
• the importation of communicable
diseases into the U.S., and
• the global spread of infectious
diseases.
The proposed study will provide
departing airport passengers with a selfadministered 35-item questionnaire and
a follow-up telephone questionnaire
four weeks after their return. There is no
cost to the respondent other than their
time.
characterize and explore this health
disparity between VFR and non-VFR
travelers.
The proposed study would be the first
to focus on travel-related health risks in
U.S resident VFR and non-VFR travelers
to Latin America. The study objectives
are to characterize and understand the
health disparities between VFR and
non-VFR travelers to Latin America by
comparing (1) pre-travel health
preparations, (2) perceived
susceptibility and severity to travelrelated communicable diseases, (3)
health-risk behaviors during travel, and
(4) compliance with prevention
measures during travel.
Knowledge gained from this study
will enable CDC to develop targeted,
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
responses/
respondent
Number of
respondents
Respondents
Average burden/response
(in hours)
Total burden
hours
Screener Interview ...........................................................................................
Self-Administered .............................................................................................
Telephone Interview ........................................................................................
2800
700
490
1
1
1
5/60
15/60
10/60
233
175
82
Total ..........................................................................................................
........................
........................
........................
490
Dated: November 8, 2006.
Joan F. Karr,
Acting Reports Clearance Officer, Centers for
Disease Control and Prevention.
[FR Doc. E6–19262 Filed 11–14–06; 8:45 am]
comments to CDC Desk Officer, Office of
Management and Budget, Washington,
DC or by fax to (202) 395–6974. Written
comments should be received within 30
days of this notice.
BILLING CODE 4163–18–P
Proposed Project
National Disease Surveillance
Program I—Case Reports—Revision—
(OMB No. 0920–0009), National Center
for Infectious Diseases (NCID), Centers
for Disease Control and Prevention
(CDC).
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–07–0009]
Agency Forms Undergoing Paperwork
Reduction Act Review
The Centers for Disease Control and
Prevention (CDC) publishes a list of
information collection requests under
review by the Office of Management and
Budget (OMB) in compliance with the
Paperwork Reduction Act (44 U.S.C.
Chapter 35). To request a copy of these
requests, call the CDC Reports Clearance
Officer at (404) 639–5960 or send an email to omb@cdc.gov. Send written
Tularemia, Typhoid Fever, and Viral
Hepatitis. Tularemia and MethicillinResistant Staphylococcus aureaus
(MRSA) are new additions to this
submission. Case report forms from state
and territorial health departments
enable CDC to collect demographic,
clinical, and laboratory characteristics
of cases of these diseases. This
information is used to direct
epidemiologic investigations, identify
and monitor trends in reemerging
infectious diseases or emerging modes
of transmission, to search for possible
causes or sources of the diseases, and
develop guidelines for prevention and
treatment. The data collected will also
be used to recommend target areas most
in need of vaccinations for selected
diseases and to determine development
of drug resistance.
Because of the distinct nature of each
of the diseases, the number of cases
reported annually is different for each.
There is no cost to respondents other
than their time. The total annual burden
hours are 13,371.
Background and Brief Description
Formal surveillance of 19 separate
reportable diseases has been ongoing to
meet the public demand and scientific
interest in accurate, consistent,
epidemiologic data. These ongoing
disease reports include: Active Bacterial
Core Surveillance (ABCs), CreutzfeldtJakob Disease(CJD), Cyclospora, Dengue,
Hantavirus, Idiopathic CD4+Tlymphocytopenia, Kawasaki Syndrome,
Legionellosis, Lyme disease, Malaria,
Plague, Q Fever, Reye Syndrome, Tickborne Rickettsial Disease, Trichinosis,
rmajette on PROD1PC67 with NOTICES1
ESTIMATE OF ANNUALIZED BURDEN HOURS
Number of
respondents
Form
ABCs ..............................................................................................................
ABCs Invasive MRSA ....................................................................................
VerDate Aug<31>2005
15:00 Nov 14, 2006
Jkt 211001
PO 00000
Frm 00038
Fmt 4703
Sfmt 4703
329
18
Number
responses/
respondent
21
256
E:\FR\FM\15NON1.SGM
15NON1
Total
responses
6,909
4,608
Hrs/response
10/60
10/60
Agencies
[Federal Register Volume 71, Number 220 (Wednesday, November 15, 2006)]
[Notices]
[Pages 66532-66533]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E6-19262]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-07-06BV]
Proposed Data Collections Submitted for Public Comment and
Recommendations
In compliance with the requirement of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for opportunity for public comment on
proposed data collection projects, the Centers for Disease Control and
Prevention (CDC) will publish periodic summaries of proposed projects.
To request more information on the proposed projects or to obtain a
copy of the data collection plans and instruments, call 404-639-5960
and send comments to Seleda Perryman, CDC Assistant Reports Clearance
Officer, 1600 Clifton Road, MS-D74, Atlanta, GA 30333 or send an e-mail
to omb@cdc.gov.
Comments are invited on: (a) Whether the proposed collection of
information is necessary for the proper performance of the functions of
the agency, including whether the information shall have practical
utility; (b) the accuracy of the agency's estimate of the burden of the
proposed collection of information; (c) ways to enhance the quality,
utility, and clarity of the information to be collected; and (d) ways
to minimize the burden of the collection of information on respondents,
including through the use of automated collection techniques or other
forms of information technology. Written comments should be received
within 60 days of this notice.
Proposed Project
Travel-Related Infectious Diseases Risk Perception, Prevention
Measures, and Behaviors during Travel to Latin America Visiting Friends
and Relatives (VFR) versus non-VFR Travelers--New--National Center for
Infectious
[[Page 66533]]
Diseases (NCID)--Centers for Disease Control and Prevention (CDC).
Background and Brief Description
The proposed project will focus on travelers visiting friends and
relatives (VFR) in Latin America. An estimated 44% of all international
travel is VFR related. Although multiple definitions exist, VFR
travelers typically refer to those who were born in a resource-poor
country, now living in a resource-rich country, and returning to their
country of birth to visit friends and relatives. VFR travelers have
received particular attention recently for being at higher risk than
other travel groups for acquiring communicable diseases during visit to
their home countries. However, there are few studies that characterize
and explore this health disparity between VFR and non-VFR travelers.
The proposed study would be the first to focus on travel-related
health risks in U.S resident VFR and non-VFR travelers to Latin
America. The study objectives are to characterize and understand the
health disparities between VFR and non-VFR travelers to Latin America
by comparing (1) pre-travel health preparations, (2) perceived
susceptibility and severity to travel-related communicable diseases,
(3) health-risk behaviors during travel, and (4) compliance with
prevention measures during travel.
Knowledge gained from this study will enable CDC to develop
targeted, theory-driven infectious diseases prevention messages, both
pre-travel and during travel, that will be specific to subpopulations
of travelers (VFR versus non-VFR). Expected outcomes of targeted
messaging include reducing
The burden of illness among travelers,
the importation of communicable diseases into the U.S.,
and
the global spread of infectious diseases.
The proposed study will provide departing airport passengers with a
self-administered 35-item questionnaire and a follow-up telephone
questionnaire four weeks after their return. There is no cost to the
respondent other than their time.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden/
Respondents Number of responses/ response (in Total burden
respondents respondent hours) hours
----------------------------------------------------------------------------------------------------------------
Screener Interview.............................. 2800 1 5/60 233
Self-Administered............................... 700 1 15/60 175
Telephone Interview............................. 490 1 10/60 82
---------------------------------------------------------------
Total....................................... .............. .............. .............. 490
----------------------------------------------------------------------------------------------------------------
Dated: November 8, 2006.
Joan F. Karr,
Acting Reports Clearance Officer, Centers for Disease Control and
Prevention.
[FR Doc. E6-19262 Filed 11-14-06; 8:45 am]
BILLING CODE 4163-18-P